HMGCR and breast cancer: Therefore, it can be suggested that the molecular mechanism of Crt hypolipidemic effect in breast tumors and both breast cancer cell lines studied here, is possibly mediated through its interaction with HMGCR active site and competitive inhibition of the enzyme.